Your browser is no longer supported. Please, upgrade your browser.
Settings
QLGN [NASD]
Qualigen Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.15 Insider Own0.10% Shs Outstand29.03M Perf Week80.62%
Market Cap46.82M Forward P/E- EPS next Y-0.66 Insider Trans40.94% Shs Float26.04M Perf Month47.83%
Income-4.70M PEG- EPS next Q-0.16 Inst Own9.80% Short Float6.11% Perf Quarter28.79%
Sales5.30M P/S8.83 EPS this Y95.80% Inst Trans13.69% Short Ratio0.31 Perf Half Y-10.99%
Book/sh0.37 P/B4.59 EPS next Y- ROA-20.60% Target Price7.75 Perf Year-50.87%
Cash/sh0.45 P/C3.81 EPS next 5Y- ROE-32.60% 52W Range0.93 - 4.66 Perf YTD-43.52%
Dividend- P/FCF- EPS past 5Y73.00% ROI-62.20% 52W High-56.40% Beta-0.62
Dividend %- Quick Ratio2.70 Sales past 5Y- Gross Margin23.80% 52W Low118.59% ATR0.28
Employees34 Current Ratio2.90 Sales Q/Q50.00% Oper. Margin- RSI (14)64.08 Volatility45.54% 14.35%
OptionableYes Debt/Eq0.00 EPS Q/Q76.00% Profit Margin-88.80% Rel Volume8.60 Prev Close1.70
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume5.18M Price2.03
Recom2.00 SMA2063.09% SMA5061.47% SMA2004.95% Volume25,449,159 Change19.52%
Nov-22-21 10:23AM  
07:43AM  
Nov-15-21 09:00AM  
Oct-19-21 09:00AM  
Sep-15-21 07:30AM  
Sep-08-21 07:30AM  
Aug-31-21 06:22AM  
Aug-23-21 09:58AM  
Aug-17-21 10:01AM  
08:00AM  
07:02AM  
Jul-14-21 07:30AM  
Jul-07-21 10:37AM  
Jun-08-21 07:30AM  
Jun-02-21 07:30AM  
May-19-21 07:30AM  
May-18-21 02:10PM  
May-14-21 01:35PM  
Apr-26-21 07:00AM  
07:00AM  
06:28AM  
Apr-19-21 01:16PM  
Apr-06-21 09:30AM  
Mar-18-21 08:30AM  
Mar-09-21 08:30AM  
Mar-08-21 08:30AM  
Mar-01-21 08:30AM  
Jan-26-21 09:00AM  
Dec-30-20 11:16AM  
Dec-22-20 09:00AM  
Dec-18-20 03:07PM  
Dec-16-20 10:25AM  
Dec-15-20 09:00AM  
Dec-08-20 09:00AM  
Dec-02-20 09:00AM  
Nov-30-20 09:40AM  
Nov-13-20 09:00AM  
Nov-05-20 09:00AM  
Oct-28-20 09:00AM  
Oct-08-20 09:00AM  
Oct-01-20 09:00AM  
Sep-21-20 11:53AM  
Sep-17-20 09:00AM  
Aug-31-20 09:00AM  
Aug-28-20 08:00AM  
Aug-20-20 08:00AM  
Aug-14-20 05:24PM  
Aug-06-20 03:59PM  
Aug-04-20 04:05PM  
Aug-02-20 05:32PM  
Jul-30-20 08:00AM  
Jul-22-20 08:00AM  
Jul-13-20 08:00AM  
Jul-10-20 04:05PM  
Jul-08-20 05:19PM  
Jul-07-20 08:00AM  
Jul-01-20 08:00AM  
Jun-10-20 08:00AM  
Jun-04-20 08:00AM  
Jun-02-20 08:00AM  
May-26-20 07:00AM  
Qualigen, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system; ALAN, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; AS1411 for treating viral-based infectious diseases; RAS-F3, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen, Inc. was founded in 1996 and is based in Carlsbad, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kruger Kurt HDirectorAug 19Buy1.238,0009,80018,000Aug 20 03:05 PM
BROIDRICK AMY S.EVP, Chief Strategy OfficerApr 26Buy2.034,5009,1354,500Apr 26 06:16 PM
Poirier Michael S.Chairman, CEO & PresidentApr 20Buy1.8011,00519,80911,005Apr 21 03:18 PM
Lotz Christopher L.Vice President of Finance, CFOApr 16Buy1.862,7005,02212,541Apr 19 06:15 AM
Kruger Kurt HDirectorDec 29Buy2.944,00011,74010,000Dec 30 06:05 AM